Sirio Pharma (300791) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.035x

Based on the latest financial reports, Sirio Pharma (300791) has a cash flow conversion efficiency ratio of 0.035x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥101.61 Million ≈ $14.87 Million USD) by net assets (CN¥2.91 Billion ≈ $425.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Sirio Pharma to measure how many days the company can operate on defensive assets alone.

Sirio Pharma - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Sirio Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sirio Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sirio Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UBISOFT ENTMT ADR 1/5 F:UEN0	N/A
SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares NASDAQ:HDL	0.087x
Golden Entertainment Inc NASDAQ:GDEN	0.062x
Suven Life Sciences Limited NSE:SUVEN	-0.368x
Depo Auto Parts Industrial Co Ltd TW:6605	0.043x
Petrovietnam Camau Fertilizer VN:DCM	0.075x
Nusantara Sawit Sejahtera JK:NSSS	0.079x
Merry Electronics Co Ltd TW:2439	-0.111x

Annual Cash Flow Conversion Efficiency for Sirio Pharma (2016–2024)

The table below shows the annual cash flow conversion efficiency of Sirio Pharma from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Sirio Pharma.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.64 Billion ≈ $386.49 Million	CN¥566.97 Million ≈ $82.97 Million	0.215x	+42.68%
2023-12-31	CN¥2.57 Billion ≈ $375.51 Million	CN¥386.08 Million ≈ $56.50 Million	0.150x	-8.63%
2022-12-31	CN¥2.70 Billion ≈ $395.32 Million	CN¥444.86 Million ≈ $65.10 Million	0.165x	+22.75%
2021-12-31	CN¥2.54 Billion ≈ $372.38 Million	CN¥341.38 Million ≈ $49.95 Million	0.134x	-8.38%
2020-12-31	CN¥2.18 Billion ≈ $319.40 Million	CN¥319.57 Million ≈ $46.76 Million	0.146x	+22.96%
2019-12-31	CN¥1.95 Billion ≈ $284.62 Million	CN¥231.60 Million ≈ $33.89 Million	0.119x	-49.11%
2018-12-31	CN¥784.05 Million ≈ $114.73 Million	CN¥183.46 Million ≈ $26.85 Million	0.234x	+175.08%
2017-12-31	CN¥580.20 Million ≈ $84.90 Million	CN¥49.35 Million ≈ $7.22 Million	0.085x	+140.25%
2016-12-31	CN¥464.98 Million ≈ $68.04 Million	CN¥-98.26 Million ≈ $-14.38 Million	-0.211x	--

About Sirio Pharma

SHE:300791 China Packaged Foods

Market Cap

$739.76 Million

CN¥5.06 Billion CNY

Market Cap Rank

#10418 Global

#2858 in China

Share Price

CN¥16.45

Change (1 day)

-1.61%

52-Week Range

CN¥16.19 - CN¥26.20

All Time High

CN¥57.47